drugset / Trial / NCT02375672
Study of Pembrolizumab in Combination With Chemotherapy for Patients With Advanced Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a multi-institutional, single arm, open-label, phase II study, including a safety run-in cohort. No randomization or blinding involved.
Timeline
- Start
- 2015-05-28
- Primary completion
- 2020-10-08
- Completion
- 2020-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pembrolizumab | Monoclonal antibody | 200 mg | Intravenous |
| Background | Leucovorin | Small molecule | 400 mg/m2 | Intravenous |
| Background | Oxaliplatin | Small molecule | 85 mg/m2 | Intravenous |
| Background | fluorouracil | Small molecule | 2400 mg/m2 | — |